Regeneron Pharmaceuticals Inc (REGN) Insider Trading
- $2,302,592,942.58
- $1,647,377,952.91
- Aug. 28, 2024
- Sanofi
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 15, 2014 | Major Shareholder | 140,632 | $345.15 | Buy | $48,539,134.80 | |
| Sept. 10, 2014 | Chairman | 10,328 | $350.07 | Sell | $3,615,522.96 | |
| Aug. 27, 2014 | Director | 2,000 | $350.31 | Sell | $700,620.00 | |
| Aug. 19, 2014 | VP | 3,611 | $350.00 | Sell | $1,263,850.00 | |
| Aug. 18, 2014 | VP | 5,875 | $353.00 | Sell | $2,073,875.00 | |
| Aug. 15, 2014 | Director | 3,000 | $349.20 | Sell | $1,047,600.00 | |
| Aug. 14, 2014 | Director | 2,000 | $347.65 | Sell | $695,300.00 | |
| Aug. 13, 2014 | Chairman | 8,028 | $340.01 | Sell | $2,729,600.28 | |
| Aug. 11, 2014 | SVP | 11,646 | $339.96 | Sell | $3,959,174.16 | |
| Aug. 11, 2014 | Chairman | 11,972 | $340.11 | Sell | $4,071,796.92 | |
| Aug. 8, 2014 | SVP | 2,841 | $340.60 | Sell | $967,644.60 | |
| Aug. 7, 2014 | SVP | 6,806 | $338.37 | Sell | $2,302,946.22 | |
| Aug. 6, 2014 | Director | 2,000 | $331.20 | Sell | $662,400.00 | |
| July 15, 2014 | Major Shareholder | 129,100 | $314.92 | Buy | $40,656,172.00 | |
| July 14, 2014 | Major Shareholder | 300,000 | $316.80 | Buy | $95,040,000.00 | |
| July 10, 2014 | Major Shareholder | 175,000 | $311.08 | Buy | $54,439,000.00 | |
| July 9, 2014 | Major Shareholder | 348,000 | $309.76 | Buy | $107,796,480.00 | |
| July 7, 2014 | Major Shareholder | 356,700 | $312.37 | Buy | $111,422,379.00 | |
| July 2, 2014 | Major Shareholder | 212,400 | $307.25 | Buy | $65,259,900.00 | |
| July 1, 2014 | Major Shareholder | 212,400 | $300.20 | Buy | $63,762,480.00 | |
| June 30, 2014 | Major Shareholder | 262,400 | $281.17 | Buy | $73,779,008.00 | |
| May 23, 2014 | SVP | 5,369 | $295.93 | Sell | $1,588,848.17 | |
| May 19, 2014 | major shareholder | 190,751 | $300.04 | Buy | $57,232,930.04 | |
| March 28, 2014 | major shareholder | 306,945 | $306.73 | Buy | $94,149,239.85 | |
| March 27, 2014 | major shareholder | 306,945 | $311.01 | Buy | $95,462,964.45 | |
| March 24, 2014 | Director | 15,000 | $302.67 | Sell | $4,540,050.00 | |
| March 24, 2014 | major shareholder | 306,945 | $307.91 | Buy | $94,511,434.95 | |
| March 21, 2014 | major shareholder | 305,115 | $321.22 | Buy | $98,009,040.30 | |
| March 20, 2014 | major shareholder | 67,703 | $328.33 | Buy | $22,228,925.99 | |
| March 17, 2014 | major shareholder | 115,711 | $328.46 | Buy | $38,006,435.06 | |
| March 17, 2014 | Director | 2,000 | $334.29 | Sell | $668,580.00 | |
| March 12, 2014 | major shareholder | 220,995 | $334.69 | Buy | $73,964,816.55 | |
| March 11, 2014 | major shareholder | 380,532 | $330.41 | Buy | $125,731,578.12 | |
| March 7, 2014 | major shareholder | 150,277 | $328.72 | Buy | $49,399,055.44 | |
| March 3, 2014 | major shareholder | 251,594 | $338.12 | Buy | $85,068,963.28 | |
| Feb. 27, 2014 | Director | 1,000 | $335.00 | Sell | $335,000.00 | |
| Feb. 25, 2014 | Director | 1,000 | $338.86 | Sell | $338,860.00 | |
| Feb. 25, 2014 | SVP | 11,871 | $339.55 | Sell | $4,030,798.05 | |
| Feb. 21, 2014 | Director | 5,000 | $340.00 | Sell | $1,700,000.00 | |
| Feb. 21, 2014 | SVP | 21,258 | $336.51 | Sell | $7,153,529.58 | |
| Feb. 20, 2014 | Director | 1,000 | $326.99 | Sell | $326,990.00 | |
| Feb. 18, 2014 | VP | 3,648 | $331.42 | Sell | $1,209,020.16 | |
| Feb. 18, 2014 | SVP | 12,865 | $332.68 | Sell | $4,279,928.20 | |
| Feb. 13, 2014 | SVP | 22,612 | $318.82 | Sell | $7,209,157.84 | |
| Feb. 12, 2014 | Insider | 88,987 | $320.33 | Sell | $28,505,205.71 | |
| Feb. 12, 2014 | Director | 1,000 | $320.62 | Sell | $320,620.00 | |
| Feb. 11, 2014 | Chairman | 11,475 | $325.10 | Sell | $3,730,522.50 | |
| Feb. 11, 2014 | VP | 5,819 | $325.00 | Sell | $1,891,175.00 | |
| Feb. 11, 2014 | Director | 5,000 | $320.00 | Sell | $1,600,000.00 | |
| Feb. 7, 2014 | major shareholder | 168,511 | $286.78 | Buy | $48,325,584.58 |
Insiders are both buying and selling Regeneron Pharmaceuticals Inc stock.
The insider traders at Regeneron Pharmaceuticals Inc are: Sanofi, Joseph L Goldstein, Robert E Landry, Arthur F Ryan, Marion Mccourt, Michael S Brown, P Roy Vagelos, George L Sing, Neil Stahl, Bonnie L Bassler, Leonard S Schleifer, Christopher R Fenimore, Joseph J Larosa, Plew Daniel P Van, George Yancopoulos, Michael S Aberman, Marc Tessier-Lavigne, Charles A Baker, Robert J Terifay, Andrew J Murphy, Joseph Goldstein, Peter Powchik, Douglas S Mccorkle, Alfred Gilman, Murray Goldberg, Plew Daniel P. Van, Plew Daniel Van, Robert E. Landry, Douglas Mccorkle, Huda Y Zoghbi, Christine A Poon, Michael Brown, Michael S. Brown, Murray A Goldberg, N Anthony Coles, William Roberts, Arthur F. Ryan, Bonnie L. Bassler, Charles A. Baker, Charles Baker, Douglas S. Mccorkle, George Sing, Jason Pitofsky, Joseph L. Goldstein, Leonard Schleifer, Michael Aberman, Robert Alexander Ingram, Robert Terifay, and Alfred G Gilman
The most active insider trader at Regeneron Pharmaceuticals Inc is Sanofi with 39 trades.
Leonard S Schleifer has sold the most Regeneron Pharmaceuticals Inc stock with a total value of $335,429,753.65.
Sanofi has bought the most Regeneron Pharmaceuticals Inc stock with a total value of $2,337,432,816.66.
The most recent insider trade for Regeneron Pharmaceuticals Inc was on Aug. 28, 2024.
The single biggest insider buy for Regeneron Pharmaceuticals Inc was from Sanofi with a total value of $125,731,578.12 on March 11, 2014.
The single biggest insider sell for Regeneron Pharmaceuticals Inc was from Leonard S Schleifer with a total value of $130,006,000.00 on Aug. 18, 2021.